Lifestance Health vs Sotera Health
Add, change or remove companies; up to four.
The short version
- Lifestance Health is the larger business, with $1.4B of revenue in fiscal 2025 against $1.2B for Sotera Health.
- Lifestance Health grew revenue faster (13.9%, against 5.7%).
- Sotera Health turned more of its sales into free cash flow (12.8% FCF margin, against 7.7%).
- Sotera Health earned a higher return on the capital invested in it (6.7%, against 1.2%).
- Investors pay more for each dollar of Lifestance Health’s earnings: a P/E of 99.5x against 31.8x for Sotera Health.
| Latest fiscal year | LFST · FY25 | SHC · FY25 |
|---|---|---|
| Size | ||
| Market cap | $5.0B | $5.2B |
| Revenue | $1.4B | $1.2B |
| Free cash flow | $110M | $149M |
| Net income | $9.7M | $77.9M |
| Growth | ||
| Revenue growth | 13.9% | 5.7% |
| 5-year growth | 46.3% | 7.3% |
| Share count change | 3.2% | 0.5% |
| Profitability | ||
| Gross margin | — | 55.5% |
| Operating margin | 1.7% | — |
| Net margin | 0.7% | 6.7% |
| FCF margin | 7.7% | 12.8% |
| Return on capital | 1.2% | 6.7% |
| Return on equity | 0.7% | 15.4% |
| Balance sheet | ||
| Net debt | $34.2M | $1.9B |
| Net debt / EBITDA | 0.5x | — |
| Dividends and buybacks | $0.0M | $0.0M |
| Valuation & quality | ||
| P/E | 99.5x | 31.8x |
| Piotroski F-score | 7 | 7 |
Revenue
FY19
LFST $213M
SHC $778M
FY20
LFST —
SHC $818M
FY21
LFST $668M
SHC $932M
FY22
LFST $860M
SHC $1.0B
FY23
LFST $1.1B
SHC $1.0B
FY24
LFST $1.3B
SHC $1.1B
FY25
LFST $1.4B
SHC $1.2B
LFST
SHC
Operating margin
FY19
LFST 7.2%
SHC 23.6%
FY20
LFST —
SHC 25.2%
FY21
LFST −42.9%
SHC 27.6%
FY22
LFST −24.5%
SHC 24.7%
FY23
LFST −17.9%
SHC 26.4%
FY24
LFST −2.5%
SHC 27.1%
FY25
LFST 1.7%
SHC —
LFST
SHC
Free cash flow
FY19
LFST $2.7M
SHC $91.8M
FY20
LFST —
SHC $67.1M
FY21
LFST −$85.1M
SHC $179M
FY22
LFST −$26.5M
SHC $95.6M
FY23
LFST −$57.4M
SHC −$363M
FY24
LFST $85.7M
SHC $45.1M
FY25
LFST $110M
SHC $149M
LFST
SHC
Return on capital
FY19
LFST —
SHC —
FY20
LFST —
SHC —
FY21
LFST —
SHC 7.6%
FY22
LFST −10.4%
SHC 9.3%
FY23
LFST −9.1%
SHC 6.3%
FY24
LFST −1.6%
SHC 6.1%
FY25
LFST 1.2%
SHC 6.7%
LFST
SHC
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.